In our study, we first revealed that downregulation of CLDN2 and upregulation of its downstream NDRG1 achieved similar EMT and CDKIs regulation in CRC, which was confirmed by the rescue experiments in another CRC cell line. This evidence concerns the gene CLDN2 and colorectal carcinoma.